Multidrug-resistant Tuberculosis
Authors: Samuel W. Dooley, William R. Jarvis, William J. Marione, Dixie E. Snider
Journal: Annals of Internal Medicine (1992)

Editorials1 August 1992Multidrug-resistant TuberculosisSamuel W. Dooley, MD, William R. Jarvis, MD, William J. Marione, MD, Dixie E. Snider Jr., MD, MPHSamuel W. Dooley, MD, William R. Jarvis, MD, William J. Marione, MD, Dixie E. Snider Jr., MD, MPHAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-117-3-257 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAs recently as 10 years ago, tuberculosis was rapidly disappearing from the United States. Reported cases of tuberculosis were decreasing an average of almost 6% each year, from over 84 000 cases in 1953 to 22 255 cases in 1984. Beginning in 1985, however, the decades-long decline in tuberculosis cases reversed dramatically, and from 1985 to 1991, an 18.4% increase was noted in reported cases (1) (Centers for Disease Control [CDC]. Unpublished data). One reason for this reversal is reactivation of latent tuberculous infection in persons infected with human immunodeficiency virus (HIV) (2, 3).Against this background of the increasing...References1. JerebKellyDooleyCauthenSnider JGSGD. Tuberculosis morbidity in the United States: Final data, 1990. MMWR 1991;40(SS-3):23-7. Google Scholar2. SelwynHartelLewisSchoenbaumVermundKlein PDVESR. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-50. CrossrefMedlineGoogle Scholar3. ReiderCauthenComstockSnider HGGD. Epidemiology of tuberculosis in the United States. Epidem Rev. 1989;11:79-98. CrossrefMedlineGoogle Scholar4. PearsonJerebFriedenCrawfordDavisDooley MJTJBS. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med. 1992;117:191-6. LinkGoogle Scholar5. FischlUttamchandaniDaikosPobleteMorenoReyes MRGRJR. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992;117:177-83. LinkGoogle Scholar6. YoumansWillistonFeldmanHinshaw GEWC. Increase in resistance of tubercle bacilli to streptomycin. A preliminary report. Mayo Clin Proc. 1946;21:126-7. Google Scholar7. RevesBlakeySniderFarer RDDL. Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. Am J Epidem. 1981;113:423-35. CrossrefMedlineGoogle Scholar8. Centers for Disease Control. Multi-drug-resistant tuberculosis— North Carolina. MMWR. 1987;35:785-7. MedlineGoogle Scholar9. Centers for Disease Control. Outbreak of multidrug-resistant tuberculosis—Texas, California, and Pennsylvania. MMWR. 1990;39:369-72. MedlineGoogle Scholar10. NardellMcInnisThomasWeidhaas EBBS. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570-5. CrossrefMedlineGoogle Scholar11. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital—Florida. MMWR. 1990;39:718-22. MedlineGoogle Scholar12. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR. 1991;40:585-91. MedlineGoogle Scholar13. EdlinTokarsGriecoCrawfordWilliamsSordillo BJMJJE. Nosocomial transmission of multidrug-resistant tuberculosis among AIDS patients: Epidemiologic studies and restriction 1992. fragment length polymorphism analysis. N Engl J Med. 1992;326:1514-21. CrossrefMedlineGoogle Scholar14. Di PerriCrucianiDanziLuzzatiDe ChecchiMalena GMMRGM. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989;2:1502-4. MedlineGoogle Scholar15. DaleySmallSchecterSchoolnikMcAdamJacobs CPGGRW. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med. 1992;326:231-5. CrossrefMedlineGoogle Scholar16. DooleyVillarinoLawrenceSalinasAmilRullan SMMLSJ. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267:2632-4. CrossrefMedlineGoogle Scholar17. SbarbaroJohnson JS. Tuberculosis chemotherapy for recalcitrant outpatients administered twice-weekly. Am Rev Respir Dis. 1968; 97:895-902. MedlineGoogle Scholar18. McDonaldMemonReichman RAL. Successful supervised ambulatory management of tuberculosis treatment failures. Ann Intern Med. 1982;96:297-302. LinkGoogle Scholar19. DooleyCastroHuttonMullanPolderSnider SKMRJD. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR. 1990;39(No. RR-17):1-29. MedlineGoogle Scholar20. . Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis. 1986;134:355-63. MedlineGoogle Scholar21. . National action plan to combat multidrug-resistant tuberculosis. United States Department of Health and Human Services, Public Health Service; Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Samuel W. Dooley, MD; William R. Jarvis, MD; William J. Marione, MD; Dixie E. SniderJr., MD, MPHAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPyrazinamide Analogs Designed for Rational Drug Designing Strategies against Resistant Tuberculosis1H, 13C, 15N backbone and side-chain NMR assignments of the C-terminal domain of Mycobacterium Tuberculosis ribosome maturation factor RimMToward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis StrainsNetwork-principled deep generative models for designing drug combinations as graph setsN -( tert -Butyl)-2-(2-nitrophenyl)imidazo[1,2- a ]pyridin-3-amineCrystal structure and Hirshfeld surface analysis of two imidazo[1,2- a ]pyridine derivatives: N - tert -butyl-2-(4-methoxyphenyl)-5-methylimidazo[1,2- a ]pyridin-3-amine and N - tert -butyl-2-[4-(dimethylamino)phenyl]imidazo[1,2- a ]pyridin-3-amineSusceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of GhanaMaximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein‐protein interaction networkT regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New DelhiNatural Remedies against Multi-Drug Resistant Mycobacterium tuberculosisToward Mapping and Sequencing the Genome of Mycobacterium tuberculosisN - tert -Butyl-2-(2,6-dichlorophenyl)imidazo[1,2-a]pyrazin-3-amineEfficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activityN - tert -Butyl-2-[4-(dimethylamino)phenyl]imidazo[1,2- a ]pyrazin-3-amineClassification and regression tree (CART) model to predict pulmonary tuberculosis in hospitalized patientsTuberculosis among Healthcare Workers, United States, 1995–2007Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae1-(3,5-Dimethoxyphenyl)-2-(4-fluorophenyl)-4,5-dimethyl-1 H -imidazoleSynthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol – The crucial role of the configurationSynthesis of 1,2,4-triazole derivatives containing benzothiazoles as pharmacologically active moleculeMolecular Modeling of Mycobacterium Tuberculosis dUTpase: Docking and Catalytic Mechanism StudiesNature-inspired Novel Drug Design Paradigm Using Nanosilver: Efficacy on Multi-Drug-Resistant Clinical Isolates of TuberculosisNovel applications of solid and liquid formulations of nanoparticles against insect pests and pathogensStructural analysis of mycobacterial branched-chain aminotransferase: implications for inhibitor designDesign, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosisImportance of improved TB diagnostics in addressing the extensively drug-resistant TB crisisBiological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in JapanA comparison of the T cell delayed-type hypersensitivity epitopes of the 19-kD antigens from Mycobacterium tuberculosis and Myco. intracellulare using overlapping synthetic peptidesReduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosisMycobacterial Diseases: Tuberculosis and LeprosyUse of NMR Metabolomics To Analyze the Targets of d -Cycloserine in Mycobacteria: Role of d -Alanine RacemaseRapid, Standardized Method for Determination of Mycobacterium tuberculosis Drug Susceptibility by Use of Mycolic Acid AnalysisRésistances de Mycobacterium tuberculosisEditorial: The treatment of multi-drug resistant tuberculosis ? a return to the pre-antibiotic era?Synthesis and antitubercular activities of bis-glycosylated diamino alcoholsAn efficient synthesis of aryloxyphenyl cyclopropyl methanones: a new class of anti-mycobacterial agentsComparison between spoligotyping and IS6110 restriction fragment length polymorphisms in molecular genotyping analysis of Mycobacterium tuberculosis strainsActivity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophagesA study of tuberculosis, malnutrition and gender in Sri LankaPathogen survival in the external environment and the evolution of virulenceEffect ofn-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCGIn-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutationsRifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain FamilyRe-emergence of tuberculosis and its variants: implications for dentistryNested PCR for diagnosis of tuberculous lymphadenitis and PCR-SSCP for identification of rifampicin resistance in fine-needle aspiratesLimited Transmission of Multidrug-Resistant Tuberculosis Despite a High Proportion of Infectious Cases in Los Angeles County, CaliforniaLaboratory Diagnosis of Mycobacterial Infections: New Tools and Lessons LearnedTuberculosis in the Eastern European Countries and the Former USSRMULTIDRUG – RESISTANT TUBERCULOSIS (MDRTB) IN CHILDRENInterleukin-1 or Tumor Necrosis Factor-α Augmented the Cytotoxic Effect of Mycobacteria on Human Fibroblasts: Application to Evaluation of Pathogenesis of Clinical Isolates of Mycobacterium tuberculosis and M. avium ComplexOrigen, presente y futuro de las resistencias en tuberculosisIssues Facing TB Control (5.1) (b) Diagnostic Issues: Molecular Technology in the Diagnosis and Treatment of TuberculosisAntimycobacterial Activities of Novel Levofloxacin AnaloguesIn vitro antimycobacterial activities of Physalis angulata LAntigenic Equivalence of Human T-Cell Responses to Mycobacterium tuberculosis -Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic PeptidesHeteroduplex mobility assay for rapid, sensitive and specific detection of mycobacteriaPreventing Multidrug-Resistant Tuberculosis and Errors in Tuberculosis Treatment Around the GlobeMultidrug-Resistant Tuberculous Iliopsoas AbscessBacteriological and Molecular Analysis of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated in AustraliaInterleukin-6 and Interleukin-12 Participate in Induction of a Type 1 Protective T-Cell Response during Vaccination with a Tuberculosis Subunit VaccineImmunogenicity of DNA Vaccines Expressing Tuberculosis Proteins Fused to Tissue Plasminogen Activator Signal SequencesMutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe AssayThe return of tuberculosisAntimycobacterial Activities of Isoxyl and New Derivatives through the Inhibition of Mycolic Acid SynthesisThe IS 6110 Restriction Fragment Length Polymorphism in Particular Multidrug-Resistant Mycobacterium tuberculosis Strains May Evolve Too Fast for Reliable Use in Outbreak InvestigationTuberculosis screening: A review and a potential role for prehospital care providersTreating TuberculosisBactericidal Activities of the Pyrrole Derivative BM212 against Multidrug-Resistant and Intramacrophagic Mycobacterium tuberculosis StrainsAntituberculosis-Drug ResistancePyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosisAn outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, ItalyAltered Cytokine Production and Impaired Antimycobacterial Immunity in Protein-Malnourished Guinea PigsGlobal Surveillance for Antituberculosis-Drug Resistance, 1994–1997Tuberculose multi-resistente. A propósito de um caso clínico de reinfeção exógena adquirida no meio prisionalResistência aos antibacilaresRespiratory Isolation of Tuberculosis Patients Using Clinical Guidelines and an Automated Clinical Decision Support SystemClinical Impact of Antibiotic ResistanceDRUG RESISTANCE IN TUBERCULOSISMolecular diagnostics of infectious diseasesTuberculosis in the hospice — a cause for concern?Management of Healthcare Workers Infected with Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, or Other Bloodborne PathogensThe treatment of tuberculosisEffects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosisHOSPITAL INFECTION CONTROL PRACTICES FOR TUBERCULOSISProfessional Healthcare Workers' Attitudes Toward Treating Patients with Multidrug-Resistant TuberculosisMultidrug-resistant tuberculosisNosocomial Colonization and Infection in Persons Infected With Human Immunodeficiency VirusNosocomial Colonization and Infection in Persons Infected with Human Immunodeficiency VirusMulti drug resistant tuberculosisPeriprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosisThe genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complexEvaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteriaOn the Development of Mycobacterial InfectionsPatterns of resistance of Mycobacterium tuberculosis in Spanish patients infected with human immunodeficiency virus type 1 (HIV-1)Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosisHIV AND TUBERULOSISIn vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosisMolecular epidemiology of tuberculosis in Denmark in 1992Tests for detection and identification of mycobacteria. How should they be used?Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosisTreatment of multidrug-resistant tuberculosisTuberculosis in the AIDS eraMolecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovisProspective study of drug-resistant tuberculosis in a spanish urban population including patients at risk for HIV infectionInfectious Complications of HIV DiseaseMolecular Biology, Virulence, and Pathogenicity of MycobacteriaAntituberculous therapyTreatment of multi-drug-resistant tuberculosisMolecular biology in the diagnosis and epidemiology of tuberculosisMycobacterium tuberculosis transmission rates in a sanatorium: implications for new preventive guidelinesAntimycobacterial susceptibility testing: Present practices and future trendsSituación actual de la tuberculosis en EspañaPneumonia in patients with HIV infectionIdentification of Genes Involved in the Resistance of Mycobacteria to Killing by MacrophagesUtility of the Hospital Tuberculosis RegistryThe Use of High-Efficiency Particulate Air-Filter Respirators to Protect Hospital Workers from Tuberculosis -- A Cost-Effectiveness AnalysisTREATMENT AND PREVENTION OF TUBERCULOSIS IN HIV-INFECTED PERSONSEvaluation of a safe sputum processing method for detecting tuberculosis.Tuberculin skin testingDirect detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test systemOral empirical treatment of pneumoniaInfectious diseasesScreening of Physicians for TuberculosisThe BCG controversyMechanisms of Drug Resistance in Mycobacterium tuberculosisHealth policies and procedures for medical students at US medical schools: a progress reportInfection Caused by Mycobacterium TuberculosisMDR-TB: Another Challenge from the Microbial WorldEarly Bactericidal and Sterilizing Activities of Ciprofloxacin in Pulmonary TuberculosisGenetics of tuberculosisThe treatment of tuberculosisThe role of the public health department in tuberculosisEnvironmental control of tuberculosisThe rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosisTherapy of multidrug-resistant tuberculosis: lessons from studies with miceThe authors replyThe authors replyTB and HIV in Healthcare SettingsMolecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive culturesDrug-resistant Tuberculosis in Puerto Rico, 1987–1990Recent Advances in Pulmonary MedicineMaking your lab safe against multi-drug-resistant Mycobacterium tuberculosisExogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV InfectionTreatment and prevention of multidrug-resistant tuberculosisRespiratory infections in the immunocompromised patientChapter 15. Recent Developments in Antibacterial Resistance MechanismsTuberculosis in Prison: Balancing Justice and Public HealthMultidrug-resistant Tuberculosis (MDRTB) 1 August 1992Volume 117, Issue 3Page: 257-259KeywordsHIVMultidrug resistant tuberculosis ePublished: 1 December 2008 Issue Published: 1 August 1992 PDF downloadLoading ...